// //
Oncology | Hematology | News and Expert Perspectives - i3 Heath News

Retacrit Approved as a Biosimilar to Epogen/Procrit

Retacrit Approved as a Biosimilar to Epogen/Procrit
The FDA has approved Retacrit (epoetin alfa-epbx, Hospira Inc., a subsidiary of Pfizer Inc.) as a biosimilar to Epogen/Procrit (epoetin alfa, Amgen Inc.) for the treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy, chr...

Navigating the Therapeutic Landscape for Patients Undergoing HSCT With Sergio Giralt, MD

Navigating the Therapeutic Landscape for Patients Undergoing HSCT With Sergio Giralt, MD
Hematopoietic stem cell transplant (HSCT) is a potentially curative therapy for patients with hematologic malignancies. There are 2 primary types of HSCT: autologous, where the cells are taken from the patient, and allogeneic, where the cells come fr...

A Simple Strategy to Reduce Bladder Cancer Recurrence

A Simple Strategy to Reduce Bladder Cancer Recurrence
A recent study published in JAMA showed that flushing the bladder with a chemotherapy drug such as gemcitabine (Gemzar, Eli Lilly and Company) and saline directly following surgery to remove cancerous tissue significantly reduced the risk for recurre...

Daratumumab Approved for Patients With Newly Diagnosed Multiple Myeloma

Daratumumab Approved for Patients With Newly Diagnosed Multiple Myeloma
​ Daratumumab (Darzalex, Janssen Pharmaceuticals, Inc.) in combination with bortezomib (Velcade, Millenium Pharmaceuticals, Inc.), melphalan, and prednisone (VMP) has received approval for the treatment of patients with newly diagnosed multiple myelo...

Dabrafenib/Trametinib Approved for BRAF V600E-Positive Anaplastic Thyroid Cancer

Dabrafenib/Trametinib Approved for BRAF V600E-Positive Anaplastic Thyroid Cancer
​ Dabrafenib plus trametinib (Taflinar and Mekinist, Novartis Pharmaceuticals Corp.) has received approval for the treatment of patients with BRAF V600E-positive, locally advanced or metastatic anaplastic thyroid cancer (ATC) in the absence of other ...